首页> 外文学位 >Mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction: An in vitro model of idiosyncratic drug-induced liver injury.
【24h】

Mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction: An in vitro model of idiosyncratic drug-induced liver injury.

机译:曲伐沙星-肿瘤坏死因子-α相互作用诱导的肝细胞凋亡机制:特异药物诱导的肝损伤的体外模型。

获取原文
获取原文并翻译 | 示例

摘要

Idiosyncratic drug-induced liver injury (IDILI) is an adverse and typically rare response to drugs that are safe in most people. Although infrequent, the response to these reactions can be severe and result in liver failure and death. Despite extensive research, the underlying mechanisms responsible for IDILI are currently unknown. One theory suggests that a modest inflammatory stress can render individuals susceptible to IDILI. Animal models based on this hypothesis demonstrated that administration of a nontoxic dose of lipopolysaccharide (LPS) to induce modest inflammation interacts with drugs associated with causing IDILI to precipitate liver injury in rodents. Trovafloxacin (TVX) is a fluoroquinolone antibiotic associated with IDILI. In mice, TVX was not hepatotoxic but became injurious during concomitant inflammation induced by LPS. The pathogenesis of this liver injury was critically mediated by the proinflammatory cytokine tumor necrosis factor-alpha (TNF). The focus of this dissertation was to test the hypothesis that TVX and TNF interact directly to cause hepatocyte cell death, and to identify critical signaling mechanisms involved in cytotoxicity. In human derived HepG2 cells, neither TVX nor TNF alone induced any cytotoxicity in vitro. However, in combination TVX/TNF treatment resulted in cytotoxicity in a concentration-dependent manner. The hepatocellular death was dependent on activated caspases and involved a prolonged activation of c-Jun N-terminal kinase (JNK). TVX has the potential to inhibit mammalian topoisomerase enzymes, which can lead to DNA damage. In hepatocytes, TVX produced DNA damage and resulted in cell cycle arrest and decreased cell proliferation. TVX also activated extracellular signal-regulated kinases (ERK) and ataxia telangiectasia and Rad3 related (ATR), both of which can be activated in response to genotoxic stress. However, none of the above events evoked cytotoxicity unless cells were also exposed to TNF. Activated ERK and ATR promoted cytotoxicity in hepatocytes exposed to both TVX and TNF. Collectively, these results contribute to increased understanding of the molecular mechanisms underlying the cytotoxic interaction of TVX and TNF. If similar mechanisms are involved in response to other IDILI associated drugs interacting with TNF to kill hepatocytes, this information could be used to develop high-throughput screening assays capable of discerning the potential of new drug candidates to cause IDILI.
机译:异质性药物诱发的肝损伤(IDILI)是对大多数人安全的药物的不良反应,通常很少见。尽管不常见,但对这些反应的反应可能很严重,并会导致肝衰竭和死亡。尽管进行了广泛的研究,但目前尚不清楚引起IDILI的潜在机制。一种理论认为适度的发炎压力可使个体易感IDILI。基于该假设的动物模型表明,无毒剂量的脂多糖(LPS)的给药可引起中等程度的炎症,它与引起IDILI引起啮齿动物肝损伤的药物相互作用。曲伐沙星(TVX)是与IDILI相关的氟喹诺酮类抗生素。在小鼠中,TVX无肝毒性,但在LPS引起的伴随炎症过程中变得有害。该肝损伤的发病机制由促炎性细胞因子肿瘤坏死因子-α(TNF)关键性介导。本论文的重点是检验TVX和TNF直接相互作用导致肝细胞死亡的假说,并确定参与细胞毒性的关键信号传导机制。在人类衍生的HepG2细胞中,TVX和TNF均不能在体外诱导任何细胞毒性。但是,TVX / TNF联合治疗以浓度依赖性方式导致细胞毒性。肝细胞死亡取决于激活的胱天蛋白酶,并涉及c-Jun N端激酶(JNK)的长时间激活。 TVX具有抑制哺乳动物拓扑异构酶的潜力,这可能导致DNA损伤。在肝细胞中,TVX产生DNA损伤,并导致细胞周期停滞和细胞增殖减少。 TVX还激活了细胞外信号调节激酶(ERK),共济失调毛细血管扩张和Rad3相关(ATR),它们都可以响应遗传毒性应激而被激活。但是,除非细胞也暴露于TNF,否则上述事件均未引起细胞毒性。活化的ERK和ATR促进了暴露于TVX和TNF的肝细胞的细胞毒性。总体而言,这些结果有助于增进对TVX和TNF细胞毒性相互作用的分子机制的了解。如果对与IDILI相关的其他药物与TNF相互作用杀死肝细胞的反应涉及相似的机制,则该信息可用于开发高通量筛选测定法,从而能够识别出候选新药物引起IDILI的潜力。

著录项

  • 作者

    Beggs, Kevin Michael.;

  • 作者单位

    Michigan State University.;

  • 授予单位 Michigan State University.;
  • 学科 Health Sciences Toxicology.;Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 216 p.
  • 总页数 216
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:41:41

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号